David E. Kang

6.7k total citations · 1 hit paper
75 papers, 5.3k citations indexed

About

David E. Kang is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David E. Kang has authored 75 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 44 papers in Physiology and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in David E. Kang's work include Alzheimer's disease research and treatments (41 papers), Cellular transport and secretion (10 papers) and Mitochondrial Function and Pathology (8 papers). David E. Kang is often cited by papers focused on Alzheimer's disease research and treatments (41 papers), Cellular transport and secretion (10 papers) and Mitochondrial Function and Pathology (8 papers). David E. Kang collaborates with scholars based in United States, France and Türkiye. David E. Kang's co-authors include Edward H. Koo, Jung A. Woo, Claus U. Pietrzik, Salvador Soriano, Eliezer Masliah, Yu Xia, Pritam Das, Sascha Weggen, Michael P. Murphy and Jason L. Eriksen and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

David E. Kang

73 papers receiving 5.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

2001 1.1k citations Claus U. Pietrzik, David E. Kang et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David E. Kang	3.0k	2.3k	1.2k	856	684	75	5.3k
George R. Jackson	2.8k 1.0×	2.4k 1.0×	1.7k 1.5×	685 0.8×	803 1.2×	88	5.5k
Colleen L. Forster	2.3k 0.8×	1.5k 0.6×	1.1k 1.0×	633 0.7×	1.0k 1.5×	56	4.3k
Mikko Hiltunen	2.6k 0.9×	2.5k 1.0×	975 0.8×	496 0.6×	936 1.4×	157	5.9k
Patrick M. Sullivan	3.5k 1.2×	3.3k 1.4×	1.4k 1.2×	689 0.8×	1.5k 2.2×	107	8.5k
Takeshi Kawarabayashi	4.1k 1.4×	2.2k 0.9×	1.3k 1.1×	889 1.0×	1.0k 1.5×	129	5.7k
Antonio Migheli	2.4k 0.8×	2.6k 1.1×	1.1k 0.9×	495 0.6×	1.4k 2.0×	83	6.1k
Yasuji Matsuoka	3.2k 1.1×	2.4k 1.0×	1.4k 1.2×	845 1.0×	1.1k 1.5×	80	5.9k
Max Holzer	3.1k 1.0×	2.3k 1.0×	1.6k 1.3×	613 0.7×	846 1.2×	89	5.0k
Jean‐Noël Octave	2.3k 0.8×	2.3k 1.0×	1.1k 0.9×	522 0.6×	584 0.9×	107	4.3k
Koichi Ishiguro	4.0k 1.3×	3.5k 1.5×	2.0k 1.7×	899 1.1×	834 1.2×	94	7.1k

Countries citing papers authored by David E. Kang

Since Specialization

Citations

This map shows the geographic impact of David E. Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Kang more than expected).

Fields of papers citing papers by David E. Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Kang. The network helps show where David E. Kang may publish in the future.

Co-authorship network of co-authors of David E. Kang

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Kang. A scholar is included among the top collaborators of David E. Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Kang. David E. Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barker, Sarah, Deborah A. Corey, Edwin Vázquez‐Rosa, et al.. (2025). Cystic Fibrosis-related neurodegenerative disease associated with tauopathy and cognitive decline in aged CF mice. Journal of Cystic Fibrosis. 24(4). 778–786.

Uversky, Vladimir N., et al.. (2025). Effects of pathological mutations on the CHCHD2 monomer structure: A study by AlphaFold3 linked to the generation of conformational ensembles. Computers in Biology and Medicine. 196(Pt B). 110810–110810.

Uversky, Vladimir N., et al.. (2025). Impacts of pathogenic mutations on the structures of the CHCHD10 monomer: An AlphaFold3 study linked to the generation of conformational ensembles. International Journal of Biological Macromolecules. 318(Pt 2). 144970–144970. 1 indexed citations

Uversky, Vladimir N., et al.. (2023). Effects of the Jokela type of spinal muscular atrophy‐related G66V mutation on the structural ensemble characteristics of CHCHD10. Proteins Structure Function and Bioinformatics. 91(6). 739–749. 5 indexed citations

Liu, Tian, et al.. (2023). Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion. Cells. 12(24). 2781–2781. 7 indexed citations

Woo, Jung A., Cynthia Koziol‐White, Steven S. An, et al.. (2023). A Par3/LIM Kinase/Cofilin Pathway Mediates Human Airway Smooth Muscle Relaxation by TAS2R14. American Journal of Respiratory Cell and Molecular Biology. 68(4). 417–429. 7 indexed citations

Woo, Jung A., Tian Liu, Yeojung Koh, et al.. (2023). Slingshot homolog-1–mediated Nrf2 sequestration tips the balance from neuroprotection to neurodegeneration in Alzheimer’s disease. Proceedings of the National Academy of Sciences. 120(30). e2217128120–e2217128120. 10 indexed citations

Liu, Tian, et al.. (2022). Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10. Acta Neuropathologica Communications. 10(1). 95–95. 15 indexed citations

Woo, Jung A., et al.. (2022). Slingshot homolog-1 mediates the secretion of small extracellular vesicles containing misfolded proteins by regulating autophagy cargo receptors and actin dynamics. Frontiers in Aging Neuroscience. 14. 933979–933979. 3 indexed citations

10.

Liu, Tian, et al.. (2021). Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models. Frontiers in Aging Neuroscience. 13. 660843–660843. 37 indexed citations

11.

Kang, David E. & Jung A. Woo. (2019). Cofilin, a Master Node Regulating Cytoskeletal Pathogenesis in Alzheimer’s Disease. Journal of Alzheimer s Disease. 72(s1). S131–S144. 48 indexed citations

12.

Liu, Tian, et al.. (2017). Cofilin-mediated Neuronal Apoptosis via p53 Translocation and PLD1 Regulation. Scientific Reports. 7(1). 11532–11532. 28 indexed citations

13.

Jeon, Jae-Pyo, Jinhong Wie, Jinsung Kim, et al.. (2013). Activation of TRPC4β by Gαi subunit increases Ca2+ selectivity and controls neurite morphogenesis in cultured hippocampal neuron. Cell Calcium. 54(4). 307–319. 34 indexed citations

14.

Palavicini, Juan Pablo, Elisabetta Bianchi, Shaohua Xu, et al.. (2013). RanBP9 aggravates synaptic damage in the mouse brain and is inversely correlated to spinophilin levels in Alzheimer’s brain synaptosomes. Cell Death and Disease. 4(6). e667–e667. 24 indexed citations

15.

Lakshmana, Madepalli K., et al.. (2009). Novel Role of RanBP9 in BACE1 Processing of Amyloid Precursor Protein and Amyloid β Peptide Generation. Journal of Biological Chemistry. 284(18). 11863–11872. 74 indexed citations

16.

Lakshmana, Madepalli K., Eunice Chen, Il‐Sang Yoon, & David E. Kang. (2008). C‐terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65. Journal of Cellular and Molecular Medicine. 12(6b). 2665–2674. 16 indexed citations

17.

Repetto, Emanuela, Il‐Sang Yoon, Hui Zheng, & David E. Kang. (2007). Presenilin 1 Regulates Epidermal Growth Factor Receptor Turnover and Signaling in the Endosomal-Lysosomal Pathway. Journal of Biological Chemistry. 282(43). 31504–31516. 69 indexed citations

18.

Yoon, Il‐Sang, Claus U. Pietrzik, David E. Kang, & Edward H. Koo. (2005). Sequences from the Low Density Lipoprotein Receptor-related Protein (LRP) Cytoplasmic Domain Enhance Amyloid β Protein Production via the β-Secretase Pathway without Altering Amyloid Precursor Protein/LRP Nuclear Signaling. Journal of Biological Chemistry. 280(20). 20140–20147. 30 indexed citations

19.

Kang, David E., Salvador Soriano, Xuefeng Xia, et al.. (2002). Presenilin Couples the Paired Phosphorylation of β-Catenin Independent of Axin. Cell. 110(6). 751–762. 198 indexed citations

20.

Saitoh, Tsunao, et al.. (1997). Glial Cells in Alzheimer's Disease: Preferential Effect of APOE Risk on Scattered Microglia. Gerontology. 43(1-2). 109–118. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact